A recent study reported that decreased levels of ADAMTS13 and increased levels of vWF levels were observed in plasma of CTEPH patients, suggesting the role of the ADAMTS13–vWF axis in CTEPH pathobiology. This evidence concerns the gene ADAMTS13 and chronic thromboembolic pulmonary hypertension.